Leigh MacMillan

October 3, 2013

Intracellular receptor expert set for next Discovery Lecture

Keith Yamamoto, Ph.D., an international leader in the study of signaling and gene regulation by intracellular receptors, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 10.

By Leigh MacMillan
October 3, 2013

Pioneers of Discovery: Computer science drives Capra’s biomedical research

Tony Capra, Ph.D., is a new assistant professor of Biomedical Informatics and investigator in the Center for Human Genetics Research at Vanderbilt. His goal is to use the tools of computer science to address problems in genetics, evolution and biomedicine.

By Leigh MacMillan
October 2, 2013

Early cell death in MS

Death of oligodendrocytes, the cells that make myelin, appears to be an early event in the development of multiple sclerosis.

By Leigh MacMillan
September 30, 2013

Gene interactions and cavities

Vanderbilt researchers used existing genome-wide association study datasets to identify gene interactions that contribute to tooth decay.

By Leigh MacMillan
September 27, 2013

Metabolic profiling of vision loss

A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis.

By Leigh MacMillan
Stomach
September 26, 2013

Cell changes en route to stomach cancer

Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer.

By Leigh MacMillan
September 26, 2013

Discovery Lecturer explores genome medicine’s impact

We’re on a potential collision course, said last week’s Flexner Discovery Lecturer, between the delivery of good medical care and the possibilities offered by genome medicine.
By Leigh MacMillan
September 18, 2013

Fishing for new anti-cancer drugs

Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug.
By Leigh MacMillan
September 16, 2013

Mapping brain membrane proteins

New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues.
By Leigh MacMillan
September 13, 2013

Cancer nanomedicines on target

Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time.
By Leigh MacMillan
September 12, 2013

VU study identifies DNA changes in drug-resistant cancer cells

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.
By Leigh MacMillan
September 12, 2013

Discovery lecturer to discuss genetic information’s challenges

Wylie Burke, M.D., Ph.D., an expert in the social, ethical and policy implications of genetic information, will deliver the next Flexner Discovery Lecture on Thursday, Sept. 19.
By Leigh MacMillan